Patent · US Active

siRNA targeting TIE-2

US7615541B2 · kind B2 · utility

51Cited by
10References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 3, 2006
Grant dateNov 10, 2009
Priority date
Expiry dateFeb 1, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/11
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.